Brittany S. Bruggeman, MD, reviews teplizumab (Tzield), islet autoantibody screening, and automated insulin delivery, and how pediatricians can help families.

Glucommander Pediatrics received FDA Breakthrough Device Designation for IV insulin dosing in hospitalized children younger than 2 years, but remains uncleared.

ISPAD, EASD, and ADA urge pediatric diabetes teams to build center-specific transition policies, use readiness checklists, and ensure timely handoffs to adult clinicians.

In a cross-sectional study of 48,118 pediatric primary care encounters, e-cigarette-only household exposure was associated with more asthma flares and activity-related symptoms.

Latine and Spanish-speaking patients had the largest increases in pediatric no-show and cancellation rates after Operation Midway Blitz, a Chicago-area immigration enforcement operation.

Sean T. O'Leary, MD, MPH, outlines 2026-2027 AAP influenza, COVID-19, and RSV guidance.

In a multi-institutional cohort of 84 patients 21 years or younger with sporadic colorectal cancer, 67 presented with stage III or IV disease and 45.2% died of CRC.

At AAP 2026, Rana Hamdy, MD, discussed when to test children for group A strep, antibiotic selection, and strategies to improve prescribing.